Diplomat Announces 3rd Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Diplomat Pharmacy (DPLO) Tops Q3 EPS by 10c; Lifts FY15 Outlook
November 3, 2015 4:20 PM ESTDiplomat Pharmacy (NYSE: DPLO) reported Q3 EPS of $0.26, $0.10 better than the analyst estimate of $0.16. Revenue for the quarter came in at $947 million versus the consensus estimate of $926.41 million.
Diplomat Pharmacy sees FY2015 EPS of $0.69-$0.73, versus prior guidance of $0.56-$0.60 and the consensus of... More
